HIGHLIGHTS
- who: Clare Macadam et al. from the Consecutive patients between , and , years old, who had previously been prescribed an auto-injector were interviewed prior to their routine clinic appointment or whilst attending the day ward for immunotherapy at Southampton University Hospitals NHS Trust (SUHT)Decisions to prescribe an auto-injector were made by a paediatric allergist on clinical lines broadly based on EAACI guidelines [14], . Following the guidelines, the majority of prescriptions were based on previous moderate or severe reactions, but some teenagers received prescriptions because of other risk factors, primarily peanut or tree nut allergy in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.